External reports (aggregated public sources), Value Investors Club

Value Investors Club (VIC)

External reports (aggregated public sources)

Value Investors Club

Equity Bottom-Up

Key points (machine generated)<ul><li>The Oncology Institute, Inc. (TOI) is a prominent cancer care organization in the U.S. that served over 72,000 patients in 2024.</li><li>TOI operates in 16 markets across 5 states, primarily California and Florida, managing care for about 1.9 million individuals through various treatment models.</li><li>Revenue is generated from three segments: Patient Services (52%), Dispensary (46%), and Clinical Trials (2%), with a focus on patient health and cost management.</li></ul>This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Key points (machine generated)The Oncology Institute, Inc. (TOI) is a prominent cancer care organization in the U.S. that served over 72,000 patients in 2024.TOI operates in 16 markets across 5 states, primarily California and Florida, managing care for about 1.9 million individuals through various treatment models.Revenue is generated from three segments: Patient Services (52%), Dispensary (46%), and Clinical Trials (2%), with a focus on patient health and cost management.This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

The Oncology Institute, Incl (TOI) - Friday, Jun 20, 2025

Independent Research, SPACs, SPAC Track

SPAC Track

Independent Research, SPACs

Equity Capital Markets

<ul><li>Waldencast Acquisition Corp. (WALD: warrants +45%) &amp; Obagi &amp; Milk Makeup (Valuation: $1.24B EV)</li><li>CHP Merger Corp. (CHPM: warrants +13.39%) &amp; Accelus (Valuation: $482M EV)</li><li>DFP Healthcare Acquisitions Corp. (DFHP) c<a href="https://www.globenewswire.com/news-release/2021/11/15/2334258/0/en/The-Oncology-Institute-Completes-Business-Combination-with-DFP-Healthcare-Acquisitions-Corp-to-Become-Publicly-Traded-Company.html?f=22&amp;fvtc=5&amp;fvtv=46464052" target="_blank" rel="noopener">ompleted its merger</a> with The Oncology Institute and began trading as TOI today</li></ul>

Waldencast Acquisition Corp. (WALD: warrants +45%) &amp; Obagi &amp; Milk Makeup (Valuation: $1.24B EV)CHP Merger Corp. (CHPM: warrants +13.39%) &amp; Accelus (Valuation: $482M EV)DFP Healthcare Acquisitions Corp. (DFHP) completed its merger with The Oncology Institute and began trading as TOI today

United States

The Oncology Institute Inc operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Oncology Institute (TOI US)

The Oncology Institute, Incl (TOI) - Friday, Jun 20, 2025

The Oncology Institute, Inc. is a leading U.S. cancer care provider, serving over 72,000 patients in 2024 through diverse treatment models and...

Value Investors Club (VIC)

The Nightcap from SPAC Track

Waldencast Acquisition Corp. (WALD: warrants +45%) & Obagi & Milk Makeup (Valuation: $1.24B EV). CHP Merger Corp. (CHPM: warrants +13.39%) &...

SPAC Track

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)